ESOPHAGUS CANCER
Clinical trials for ESOPHAGUS CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGUS CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called CRPA1A2 in people with advanced solid tumors (lung, esophagus, head and neck, or liver cancer) that have not responded to standard treatments. The drug is designed to help the body's immune cells attack cancer cells that have a speci…
Matched conditions: ESOPHAGUS CANCER
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New PET imaging could reveal where cancer drugs go in real time
Diagnosis Not yet recruitingThis study will test a new type of PET scan that uses a radioactive label to track an immunotherapy drug (ivonescimab) in the body. The goal is to see how well the drug reaches and binds to esophageal tumors without needing a biopsy. About 50 adults with esophageal cancer will re…
Matched conditions: ESOPHAGUS CANCER
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 26, 2026 08:59 UTC
-
Remote exercise may boost chemo tolerance in cancer patients
Symptom relief Not yet recruitingThis study tests if a home-based exercise program can help people with stomach, esophagus, pancreas, colon, rectal, or lung cancer better tolerate chemotherapy. About 120 adults will be randomly assigned to either an aerobic and resistance exercise program or a stretching program…
Matched conditions: ESOPHAGUS CANCER
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC